NEW YORK (GenomeWeb News) — MDS today reported that first-quarter revenue for its Sciex division increased 1.5 percent, though organic receipts increased 4 percent.
 
Total revenue for the three months ended Dec. 31, 2006, increased to $62 million from $61 million.
 
Driving revenue were the small molecule and applied markets and in Europe, MDS said.
 
MDS also said end-user revenue in the company’s joint ventures increased 10 percent.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.